SG Americas Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,100
| Closed | -$1.44M | – | 3478 |
|
|
2025
Q1 | $1.44M | Sell |
7,100
-3,500
| -33% | -$2.41M | ﹤0.01% | 932 |
|
|
2024
Q4 | $1.47M | Sell |
10,600
-1,200
| -10% | -$1.01M | 0.01% | 701 |
|
|
2024
Q3 | $160K | Buy |
11,800
+1,200
| +11% | +$1.34M | ﹤0.01% | 2670 |
|
|
2024
Q2 | $152K | Sell |
10,600
-8,100
| -43% | -$7.85M | ﹤0.01% | 2315 |
|
|
2024
Q1 | $179K | Sell |
18,700
-4,900
| -21% | -$4.66M | ﹤0.01% | 2056 |
|
|
2023
Q4 | $149K | Hold |
23,600
| – | – | ﹤0.01% | 2427 |
|
|
2023
Q3 | $316K | Buy |
23,600
+3,500
| +17% | +$2.75M | ﹤0.01% | 2049 |
|
|
2023
Q2 | $624K | Buy |
20,100
+12,300
| +158% | +$9.48M | ﹤0.01% | 1301 |
|
|
2023
Q1 | $128K | Buy |
+7,800
| New | +$5.88M | ﹤0.01% | 2751 |
|
|
2021
Q1 | – | Sell |
-19,200
| Closed | -$2.21M | – | 3506 |
|
|
2020
Q4 | $2.21M | Buy |
19,200
+7,000
| +57% | +$3.78M | 0.01% | 1030 |
|
|
2020
Q3 | $711K | Buy |
+12,200
| New | +$7.4M | ﹤0.01% | 1408 |
|
|
2020
Q2 | – | Sell |
-35,000
| Closed | -$642K | – | 3825 |
|
|
2020
Q1 | $642K | Sell |
35,000
-48,500
| -58% | -$20M | 0.01% | 1631 |
|
|
2019
Q4 | $714K | Buy |
83,500
+18,500
| +28% | +$6.22M | 0.01% | 1506 |
|
|
2019
Q3 | $5.45M | Sell |
65,000
-14,000
| -18% | -$4.14M | 0.04% | 430 |
|
|
2019
Q2 | $4.97M | Sell |
79,000
-31,300
| -28% | -$10.4M | 0.03% | 531 |
|
|
2019
Q1 | $2.17M | Sell |
110,300
-36,700
| -25% | -$15.1M | 0.02% | 801 |
|
|
2018
Q4 | $2.47M | Sell |
147,000
-1,700
| -1% | -$622K | 0.02% | 734 |
|
|
2018
Q3 | $2.07M | Buy |
148,700
+22,100
| +17% | +$8.41M | 0.02% | 1144 |
|
|
2018
Q2 | $4.08M | Buy |
126,600
+5,100
| +4% | +$1.6M | 0.04% | 523 |
|
|
2018
Q1 | $5.24M | Buy |
121,500
+96,100
| +378% | +$33.4M | 0.04% | 396 |
|
|
2017
Q4 | $1.49M | Hold |
25,400
| – | – | 0.01% | 1081 |
|
|
2017
Q3 | $1.14M | Buy |
+25,400
| New | +$12.1M | 0.01% | 1165 |
|
|
2016
Q2 | – | Sell |
-24,300
| Closed | -$2.26M | – | 2917 |
|
|
2016
Q1 | $2.26M | Sell |
24,300
-58,900
| -71% | -$24.3M | 0.02% | 794 |
|
|
2015
Q4 | $1.17M | Buy |
+83,200
| New | +$45.1M | 0.01% | 1036 |
|
|
2015
Q3 | – | Sell |
-70,900
| Closed | -$1.32M | – | 2594 |
|
|
2015
Q2 | $1.32M | Buy |
+70,900
| New | +$34.6M | 0.01% | 922 |
|
|
2015
Q1 | – | Sell |
-50,000
| Closed | -$68K | – | 2977 |
|
|
2014
Q4 | $68K | Hold |
50,000
| – | – | ﹤0.01% | 2980 |
|
|
2014
Q3 | $1.36M | Buy |
+50,000
| New | +$16.8M | 0.01% | 1035 |
|
Other funds holding REGN
VCM
N
SG Americas Securities's REGN Position: Q1 2026 in Review
SG Americas Securities increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q1 2026, buying an estimated $20.8M and bringing the position to 158,278 shares worth $122M. The position accounts for 0.13% of the portfolio, ranked #131.
SG Americas Securities first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- SG Americas Securities held 158,278 shares of Regeneron Pharmaceuticals worth $122M as of Q1 2026.
- SG Americas Securities bought 27,166 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $20.8M.
- Regeneron Pharmaceuticals made up 0.13% of SG Americas Securities's portfolio in Q1 2026, its #131 holding.
- SG Americas Securities first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.